Sandra Calvin

Insider Reports History

Entity
Individual
Location
3611 Valley Center Drive, Suite 300, San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Calvin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Common Stock 52K $444K $8.53 Feb 1, 2024 Direct
Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Employee stock option (right to buy) 25K Jan 31, 2024 Direct

Insider Reports Filed by Sandra Calvin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TVTX Travere Therapeutics, Inc. Jan 31, 2024 4 -$24.1K 4 Feb 2, 2024 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Jan 23, 2024 1 -$8.25K 4 Jan 25, 2024 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. May 10, 2023 2 -$9.2K 4 May 12, 2023 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2023 4 -$44.4K 4 Feb 2, 2023 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Jan 24, 2023 2 -$24K 4 Jan 26, 2023 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Sep 13, 2022 1 -$9.77K 4 Sep 15, 2022 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. May 10, 2022 2 -$19.1K 4 May 12, 2022 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2022 3 -$21.2K 4 Feb 2, 2022 VP, Corp Controller and CAO
TVTX Travere Therapeutics, Inc. Jan 24, 2022 1 -$23K 4 Jan 26, 2022 VP, Corp Controller and CAO
TVTX Travere Therapeutics, Inc. Sep 15, 2021 0 $0 3 Sep 23, 2021 VP, Corp Controller and CAO